U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07062016) titled 'Molecular and ctDNA Characterization of High-Risk Endometrial Cancer' on July 02.
Brief Summary: This study seeks to better understand the recurrence of high-risk endometrial cancer. It will collect information about cancer genetics to find out various hereditary or cancer specific genetic variants that may have a role in diagnosis or management and prognosis of cancer. It also seeks to develop a genetic results and medical record databank for future studies.
Study Start Date: Aug. 31
Study Type: OBSERVATIONAL
Condition:
Endometrial Carcinoma
Endometrial High Grade Endometrioid Adenocarcinoma
Stage II Endometrial Cancer
Stage II...